Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: A review

British Journal of Anaesthesia

Volumn 114, Issue 1, 2015, Pages 44-52

  De Waal, B A ^a   Buise, M P ^b   Van Zundert, A A J ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Patient outcome; Perioperative period; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; HEART INFARCTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; META ANALYSIS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; HEART SURGERY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK; STATISTICS AND NUMERICAL DATA; STROKE;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; STROKE;

EID: 84925555459     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu295     Document Type: Review

References (28)

1. Skrlin S, Hou V. A review of perioperative statin therapy for noncardiac surgery. Semin Cardiothorac Vasc Anesth 2010;14:283-90
2. Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. AmJ Cardiovasc Drugs 2008;8:373-418
3. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. J Am Med Assoc 2004;291:2092-9
4. Zhou Q, Liao JK. Pleiotropic effects of statins. Circ J 2010;74:818-26
5. Illingworth DR, Tobert JA. HMG-CoA reductase inhibitors. Adv Protein Chem 2001;56:77-114
6. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 2009;339:b2535
7. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557-60
8. Conly J, Clement F, Tonelli M, et al. Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk. Can Med Assoc J 2011;183:E1180-8
9. Egger M, Smith DG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-34
10. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999;15:394-9
11. Florens E, Salvi S, Peynet J, et al. Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. J Card Surg 2001;16:232-9
12. Durazzo AES, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004;39:967-76
13. Chello M, Patti G, Candura D, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006;34:660-7
14. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of post-operative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin forReduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation 2006;114:1455-61
15. Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardiopulmonary bypass. Eur Cytokine Netw 2008;19:99-103
16. Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008;136:1541-8
17. Song YB, On YK, Kim JH, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J 2008;156:373.e9-16
18. Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg 2009;57:91-5
19. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery, arandomizedcontrolled trial (Decrease IV). Ann Surg 2009;249:921-6
20. Ji Q, Mei Y, Wang X, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J 2009;73:2244-9
21. Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009;361:980-9
22. Tamayo E, Álvarez FJ, Alonso O, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. J Cardiovasc Surg 2009;50:687-94
23. Spadaccio C, Pollari F, Casacalenda A, et al. Atorvastain increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol 2010;55:30-8
24. Sun Y, Ji Q, Mei Y, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J 2011;52:7-11
25. Baran Ç, Durdu S, Dalva K, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev Rep 2012;8:963-71
26. Silva M, Matthews ML, Jarvis C, et al. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther 2007;29:253-60
27. Armitage J. The safety of statins in clinical practise. Lancet 2007;370:1781-90
28. Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90